De Yong Wen
Chief Executive Officer at SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.
Net worth: 611 566 $ as of 2024-04-29
Profile
De Yong Wen is currently the Co-Chief Executive Officer & Executive Director at Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
He is also the Chairman-Supervisory Board at China National Accord Medicines Corp.
Ltd., a Non-Executive Director at Sinopharm Group Co., Ltd., a Director at China National Medicines Co., Ltd., a Director at Sinopharm Industrial Investment Co., Ltd., and a Non-Executive Director at Shanghai Henlius Biotech, Inc. Previously, Mr. Wen held positions as Vice Chairman at Chongqing Yao Pharmaceutical Co., Ltd.
and Director at C.Q.
Pharmaceutical Holding Co., Ltd.
Mr. Wen obtained an MBA from Donghua University in 2007 and an undergraduate degree from West China University of Medical Sciences in 1995.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2022-12-12 | 187,100 ( 9.50% ) | 611 566 $ | 2024-04-29 |
De Yong Wen active positions
| Companies | Position | Start |
|---|---|---|
| SINOPHARM GROUP CO. LTD. | Director/Board Member | 2017-08-31 |
| CHINA NATIONAL MEDICINES CORPORATION LTD. | Director/Board Member | 2019-05-08 |
| SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. | Chief Executive Officer | 2022-05-31 |
| SHANGHAI HENLIUS BIOTECH, INC. | Director/Board Member | 2022-07-27 |
| CHINA NATIONAL ACCORD MEDICINES CORPORATION LTD. | Chairman | 2019-07-09 |
Sinopharm Industrial Investment Co., Ltd.
 Sinopharm Industrial Investment Co., Ltd. Financial ConglomeratesFinance Sinopharm Industrial Investment Co., Ltd. engages in the provision of industrial investment services. Its business activities include management of pharmaceutical business, asset restructuring and investment advisory services. The company was founded on May 6, 2008 and is headquartered in Shanghai, China. | Director/Board Member | 2020-01-19 |
Former positions of De Yong Wen
| Companies | Position | End |
|---|---|---|
Chongqing Yao Pharmaceutical Co., Ltd.
 Chongqing Yao Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Yao Pharmaceutical Co., Ltd. engages in pharmaceutical manufacture, It integrates with research and development, manufacturing, marketing, and sales of medicines. The company was founded on July 21, 1997 and is headquartered in Chongqing, China. | Director/Board Member | - |
| C.Q. PHARMACEUTICAL HOLDING CO., LTD. | Director/Board Member | - |
Training of De Yong Wen
| West China University of Medical Sciences | Undergraduate Degree |
| Donghua University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 6 |
|---|---|
| C.Q. PHARMACEUTICAL HOLDING CO., LTD. | Health Technology |
| SINOPHARM GROUP CO. LTD. | Distribution Services |
| CHINA NATIONAL MEDICINES CORPORATION LTD. | Health Technology |
| SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. | Health Technology |
| SHANGHAI HENLIUS BIOTECH, INC. | Health Technology |
| CHINA NATIONAL ACCORD MEDICINES CORPORATION LTD. | Health Technology |
| Private companies | 2 |
|---|---|
Chongqing Yao Pharmaceutical Co., Ltd.
Chongqing Yao Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Yao Pharmaceutical Co., Ltd. engages in pharmaceutical manufacture, It integrates with research and development, manufacturing, marketing, and sales of medicines. The company was founded on July 21, 1997 and is headquartered in Chongqing, China. | Health Technology |
Sinopharm Industrial Investment Co., Ltd.
Sinopharm Industrial Investment Co., Ltd. Financial ConglomeratesFinance Sinopharm Industrial Investment Co., Ltd. engages in the provision of industrial investment services. Its business activities include management of pharmaceutical business, asset restructuring and investment advisory services. The company was founded on May 6, 2008 and is headquartered in Shanghai, China. | Finance |
- Stock Market
- Insiders
- De Yong Wen
